Diabetes Core Update cover image

Diabetes Core Update – May 2023

Diabetes Core Update

00:00

The Randomized, Multi-Centered Parallel Arm Clinical Trial

The TSLIMX2 with control IQ was tested in the two to six year old, that was tested above six years old or above 14 years old before. And we were able to execute that clinical trial in the middle of the pandemic. The hypoglycemia was not very high to start with, and it stayed very low for both groups. But what really differentiated the two groups was the time in range, which is the percent of the time that people are between 70 and 180 milligram per deciliter as measured by the continuous glucose monitor. That was 12 and a half percent higher percentage point, not relative percentage pointHigher in the AID group compared to the standard

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app